Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,400 | 132,100 | 56,900 | 257,400 | 117,000 |
| Marketable Securities | 0 | 8,800 | 58,000 | 81,400 | 33,700 |
| Receivables | 121,200 | 114,300 | 101,600 | 91,300 | 89,500 |
| Inventories | 27,500 | 22,000 | 20,100 | 15,300 | 27,100 |
| TOTAL | $298,000 | $313,600 | $274,600 | $484,800 | $389,400 |
| Non-Current Assets | |||||
| PPE Net | 117,400 | 119,000 | 83,400 | 43,500 | 40,700 |
| Investments And Advances | 0 | 0 | 54,800 | 59,000 | 21,000 |
| Intangibles | 548,700 | 636,900 | 666,500 | 643,300 | 905,700 |
| Other Non-Current Assets | 63,500 | 77,000 | 119,400 | 90,100 | 62,000 |
| TOTAL | $729,600 | $832,900 | $924,100 | $835,900 | $1,029,400 |
| Total Assets | $1,027,600 | $1,146,500 | $1,198,700 | $1,320,700 | $1,418,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 32,300 | 25,800 | 28,800 | 29,600 | 20,500 |
| Accrued Expenses | 119,000 | 113,900 | 94,300 | 161,700 | 79,100 |
| TOTAL | $164,100 | $155,900 | $137,200 | $204,300 | $145,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,600 | 38,500 | N/A | N/A | 224,800 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 32,700 |
| Other Non-Current Liabilities | 122,800 | 168,900 | 175,700 | 112,800 | 95,800 |
| TOTAL | $162,400 | $207,400 | $175,700 | $148,600 | $391,900 |
| Total Liabilities | $326,500 | $363,300 | $312,900 | $352,900 | $537,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,309 | 89,875 | 81,224 | 80,023 | N/A |
| Common Shares | 900 | 900 | 800 | 800 | 800 |
| Retained earnings | -756,800 | -629,500 | -366,200 | -254,200 | -227,000 |
| Other shareholders' equity | -800 | -3,700 | -8,900 | -5,100 | -2,300 |
| TOTAL | $701,100 | $783,200 | $885,800 | $967,800 | $881,000 |
| Total Liabilities And Equity | $1,027,600 | $1,146,500 | $1,198,700 | $1,320,700 | $1,418,800 |